2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now
The Motley Fool
MARCH 31, 2024
J&J's overall net sales of $85 billion in 2023 were up 7% from 2022. The medical device business generated net sales of $30 billion, up 12% operationally from 2022, with its Abiomed subsidiary serving as a key driver of this segment's growth. Abiomed is a heart pump specialist acquired by Johnson & Johnson in 2022.
Let's personalize your content